Autophagy: Friend or Foe in Breast Cancer Development, Progression, and Treatment
Author(s) -
Damián E. Berardi,
Paola B. Campodónico,
María Inés Díaz Bessone,
Alejandro J. Urtreger,
Laura B. Todaro
Publication year - 2011
Publication title -
international journal of breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 15
eISSN - 2090-3170
pISSN - 2090-3189
DOI - 10.4061/2011/595092
Subject(s) - autophagy , programmed cell death , medicine , cancer research , apoptosis , microbiology and biotechnology , cell , suppressor , cancer , biology , biochemistry
Autophagy is a catabolic process responsible for the degradation and recycling of long-lived proteins and organelles by lysosomes. This degradative pathway sustains cell survival during nutrient deprivation, but in some circumstances, autophagy leads to cell death. Thereby, autophagy can serve as tumor suppressor, as the reduction in autophagic capacity causes malignant transformation and spontaneous tumors. On the other hand, this process also functions as a protective cell-survival mechanism against environmental stress causing resistance to antineoplastic therapies. Although autophagy inhibition, combined with anticancer agents, could be therapeutically beneficial in some cases, autophagy induction by itself could lead to cell death in some apoptosis-resistant cancers, indicating that autophagy induction may also be used as a therapy. This paper summarizes the most important findings described in the literature about autophagy and also discusses the importance of this process in clinical settings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom